Altman Clinical and Translational Research Institute - Center for Clinical Research — La Jolla, California

Altman Clinical and Translational Research Institute - Center for Clinical Research is a clinical research site located in La Jolla, California, United States 92037.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Altman Clinical and Translational Research Institute - Center for Clinical Research has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM).

Sponsors: Ionis Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Altman Clinical and Translational Research Institute - Center for Clinical Research?

Altman Clinical and Translational Research Institute - Center for Clinical Research has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Altman Clinical and Translational Research Institute - Center for Clinical Research conducted?

Altman Clinical and Translational Research Institute - Center for Clinical Research has 1 clinical trials on record, with 1 currently active. Their work covers Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM).

Is Altman Clinical and Translational Research Institute - Center for Clinical Research accredited by Crixeo Health?

Altman Clinical and Translational Research Institute - Center for Clinical Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Altman Clinical and Translational Research Institute - Center for Clinical Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.